Career Award Recipients
Billy Kim, M.D.
Determining the Role of HIF1 and HIF2 in VHL associated tumorigenesis
Pankaj Seth, Ph.D.
Gene Profiling of Renal Cancer Cell Endothelium
Won Han, M.D.
Human Kidney Cancer Injury Molecule-1 in RCC
Robert Ross, M.D.
3*, 4, 5
Evaluation of the response and resistance of kidney cancer to VEGF and/or mTor-pathway inhibitor with MION-enhanced MRI
Daniel Cho, M.D.
Enhancing the efficacy of sorafenib and sunitinib in the treatment of advanced RCC by concurrent inhibition of additional kinases
Lianjie Li, Ph.D
The biochemichal analysis of the differential risk of RCC associated with Type 2A and Type 2B vHL disease
Kevin Courtney, M.D, Ph.D.
Evaluation of phosphoinositide 3-kinase (PI3K) and CXCR4 activation in renal cell carcinoma
Rupal Bhatt, M.D. (Pfizer)
The balance of angiogenesis and angiostasis determines response and resistance to antiangiogenic therapies.
Michael Zimmer, Ph.D. (Pfizer)
Small molecule screen uncovers IRP1-mediated HIF translational repression